Two case reports of brain metastases in patients with pancreatobiliary neuroendocrine carcinoma
暂无分享,去创建一个
N. Sasahira | A. Kasuga | Takashi Sasaki | Takafumi Mie | Tsuyoshi Takeda | M. Matsuyama | M. Ozaka | Ryo Kanata | T. Furukawa
[1] T. Gress,et al. Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome , 2019, BMC Cancer.
[2] Matthew P. Goetz,et al. NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .
[3] Suneel D. Kamath,et al. Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease , 2018, Front. Oncol..
[4] J. Shiode,et al. Rare case of a gallbladder neuroendocrine carcinoma , 2018, Clinical Journal of Gastroenterology.
[5] R. Soffietti,et al. Mechanisms and Therapy for Cancer Metastasis to the Brain , 2018, Front. Oncol..
[6] P. Brown,et al. Outcomes of stereotactic radiosurgery of brain metastases from neuroendocrine tumors. , 2018, Neuro-oncology practice.
[7] Alexander Radbruch,et al. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) , 2017, Neuro-oncology.
[8] Mupeng Li,et al. Environmental Research and Public Health New Immunotherapy Strategies in Breast Cancer , 2022 .
[9] M. Ahluwalia,et al. Novel therapeutic agents in the management of brain metastases. , 2017, Current opinion in oncology.
[10] G. Barnett,et al. Management of Brain Metastasis in Patients With Pulmonary Neuroendocrine Carcinomas , 2016, Technology in cancer research & treatment.
[11] K. Blackwell,et al. Embracing rejection: Immunologic trends in brain metastasis , 2016, Oncoimmunology.
[12] D. Morgensztern,et al. Immune checkpoint inhibition in patients with brain metastases. , 2016, Annals of translational medicine.
[13] H. Sorbye,et al. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas , 2016, Neuroendocrinology.
[14] S. Tretli,et al. Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010 , 2015, Neuroendocrinology.
[15] Z. Geng,et al. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma. , 2015, International journal of clinical and experimental pathology.
[16] R. Jandial,et al. Current and emerging treatments for brain metastases. , 2015, Oncology.
[17] A. Mehrabi,et al. Brain metastasis from gastrointestinal cancers: a systematic review , 2014, International journal of clinical practice.
[18] R. Jensen,et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis , 2014, Journal of Gastroenterology.
[19] N. Lin. Targeted Therapies in Brain Metastases , 2013, Current Treatment Options in Neurology.
[20] M. V. van Velthuysen,et al. Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry. , 2013, European journal of cancer.
[21] R. Soffietti,et al. Targeted therapy in brain metastasis , 2012, Current opinion in oncology.
[22] A. Cardona,et al. Chemotherapy for brain metastases from small cell lung cancer. , 2012, The Cochrane database of systematic reviews.
[23] M. Mehta,et al. Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment. , 2011, Current cancer therapy reviews.
[24] Qinghua Zhou,et al. Comparisons between the National Comprehensive Cancer Network (NCCN) non‐small‐cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009 , 2010, Thoracic cancer.
[25] Manal M. Hassan,et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] C. Ko,et al. Rare tumors of the colon and rectum: a national review , 2006, International Journal of Colorectal Disease.
[27] M. Kidd,et al. An Analysis of Rare Carcinoid Tumors: Clarifying These Clinical Conundrums , 2004, World Journal of Surgery.